Abstract

Purpose Utilization of traditional medicines increased worldwide. However, lack of modern technology creates problems for rejection of such preparations. Good manufacturing practices (GMPs) advocate uniformity and stability in the development of modern pharmaceuticals. Implementation of appropriate formulation strategies may enhance regulatory acceptance of complementary medicines. Herewith an attempt has been made to identify the impact of process parameter temperature, pH, and yeast cell number (inoculum volume) on manufacturing of ayurvedic fermented cardiotonic—arjunarishta.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.